Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GooDMomS2: Lifestyle Intervention vs Metformin in Postpartum Women With Recent Gestational Diabetes
NCT06948825Phase 2Recruiting
- Sponsor
- George Washington University
- Start
- Oct 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in obesity, Overweight, sponsored by George Washington University. Started Oct 2025; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT06948825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06948825.